4LL.F • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 4LL.F in your mock portfolio yet.
Teladoc Health remains unprofitable, as indicated by its negative EPS and PE ratio. The current valuation reflects ongoing losses rather than earnings power, suggesting that the business model has yet to translate scale into sustainable profitability. Without clear evidence of margin expansion or a path to positive net income, the financial profile is a headwind for the stock.
The stock’s 24.1% decline over the last month, combined with a price far below its 200-day moving average, signals a strong downtrend. An RSI near 30 suggests the shares are approaching oversold territory, but this is occurring within a clearly negative technical setup. Overall, the chart structure points to persistent selling pressure with only tentative potential for a short-term bounce.
Operational and demand-side indicators are mixed but generally stable to slightly positive. Strong app download volumes with double-digit month-over-month growth and rising job openings suggest ongoing investment and user engagement. However, modest or flat social media traction and limited context on web traffic growth temper the strength of these signals.
Teladoc Health’s stock is under clear technical pressure and remains anchored by a loss-making financial profile, leading to an overall bearish stance. While alternative data such as app download growth and increased hiring indicate underlying demand and continued investment, these positives are not yet translating into profitability or price stability. Until there is clearer evidence of improving earnings and a reversal of the downtrend, the risk-reward profile appears skewed to the downside.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: